Rebates that reduce Part D premiums for Medicare Advantage plans with drug coverage make it harder for stand-alone prescription drug plans (PDPs) to compete.
That may contribute to instability in the PDP market relied on by people in traditional Medicare: https://t.co/C4lWUiwu0W
Our new brief explores changes in the number of insurers participating in the ACA Marketplaces in 2026, which fell, on average, following the expiration of the enhanced premium tax credits at the end of 2025: https://t.co/j5pQvpZnXm
KFF’s new interactive tool tracks changes in ACA insurer participation, including the recently announced exits by Cigna Health, CareSource, PacificSource, Providence Health, Scott and White, and Taro Health: https://t.co/nF7ydDXlzk
In 2026, Medicare Advantage plans are projected to use $53 per member per month in rebates to reduce Part D premiums — more than 3 times the $16 per member in temporary premium subsidies available to stand-alone Part D plans.
New KFF analysis: https://t.co/8A1LIeK9l4
How do we know if AI use in health care actually makes patients better?
@chipkahn and Dr. David Bates discuss how real-time measurement of patient outcomes can unlock progress across all areas of health care administration — and help ensure AI delivers meaningful impact. https://t.co/fHRIAtAdY5
Our latest edition of The Monitor highlights how official federal actions are elevating unverified or uncommon outcomes in debates over vaccine safety and gender-affirming care. https://t.co/LbW6TIeRmQ
More than a year after federal DEI initiatives were dismantled, staff cuts, program eliminations, grant terminations, and reduced data collection are impacting efforts to track and address health disparities. https://t.co/zFyvDqEqiq
The number of Part D stand-alone Rx drug plan options for the average Medicare beneficiary has fallen by half in recent years, while Medicare Advantage drug plan options have risen — in part due to an uneven level of premium subsidies available in each market. https://t.co/C4lWUiwu0W
The average number of issuers offering plans in the ACA Marketplaces has declined from a record high of 9.6 issuers per state in 2025 to 9.0 issuers per state in 2026: https://t.co/j5pQvpZnXm
Despite modest enrollment growth in stand-alone prescription drug plans, Medicare Advantage remains the primary source of Part D coverage, with 31.4 million enrollees.
New analysis examines enrollment, premiums, cost sharing in 2026, and trends over time: https://t.co/9olIZ6JdCZ
Six health insurers have announced that they will exit ACA Marketplaces across 18 states next year.
Track which insurers are leaving with our new tool: https://t.co/nF7ydDXlzk
This week, The Monitor covers two recent federal actions, including a memo about alleged COVID-19 vaccine deaths and legal settlements creating a “detransition clinic,” and how their representation has lent credibility to unsupported narratives. https://t.co/LbW6TIeRmQ
U.S. government and Global Fund cuts will reduce health support to 29 countries by $4.3 billion (24%) through 2029, marking an unprecedented decline in the modern era of global health funding.
More from our experts: https://t.co/PUd4OSpF9R
Our experts analyzed how much funding will decline under the Trump administration’s America First Global Health Strategy and by the Global Fund from 2026 to 2029, compared with previous years, in 29 countries with signed MOUs and available data: https://t.co/PUd4OSpF9R
Learn about recent federal actions related to Medicaid program integrity, including federal payment deferrals for potential fraud/abuse in MN and CA and the decertification of HI’s Medicaid Fraud Control Unit: https://t.co/R4RJFk7jCl
So many changes at KFF. I’m still in denial about this one! @tricia_neuman is an icon of health policy. Happy retirement, Tricia!
And congrats to @jcubanski and @jeanniebin who will be leading KFF’s Medicare team
Congrats to my colleague @jrovner! There is no better recipient of this award than Julie, who has deftly covered health policy for decades, with an encyclopedic knowledge of the issues like Robert. (Minus some of Robert's quirks, like taking notes in multiple colors.)